Literature DB >> 29214767

Catheter-related Bloodstream Infection due to Lodderomyces elongisporus in a Patient with Lung Cancer.

Hye Young Lee1, Soo Jung Kim1, Duckhee Kim1, Jeonghyun Jang1, Heungsup Sung1, Mi Na Kim2, Chang Min Choi3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29214767      PMCID: PMC5736682          DOI: 10.3343/alm.2018.38.2.182

Source DB:  PubMed          Journal:  Ann Lab Med        ISSN: 2234-3806            Impact factor:   3.464


× No keyword cloud information.
Dear Editor, Lodderomyces elongisporus was first described as a cause of bloodstream infections in 2008 [1]. We present a case of L. elongisporus fungemia in a patient with lung cancer who had a central venous catheter. A 56-year-old female presented at the emergency department of Asan Medical Center (Seoul, Korea) complaining of dyspnea. She had undergone a left lung lobectomy because of non-small cell lung cancer and had been treated with high-dose dexamethasone and cord decompression surgery for spinal cord metastasis two months ago; she was then treated with meropenem and teicoplanin for one week, owing to methicillin-resistant Staphylococcus aureus bacteremia. She was subsequently transferred to a secondary care hospital, in which a peripherally inserted central catheter had been placed for chemotherapy with docetaxel and antimicrobials. This study was performed retrospectively and was exempt from the requirements of informed consent and ethical approval. Initial vital signs revealed a spiking fever up to 40℃. Abnormal laboratory findings included a peripheral leukocyte count of 19.9×109/L, platelets at 69×109/L, C-reactive protein at 1,937.2 nmol/L, lactate dehydrogenase at 6.13 µkat/L, prothrombin time of 14.2 seconds, activated partial thromboplastin time of 42.8 seconds, and D-dimer at 72.3 nmol/L. Chest computed tomography showed pleural effusion with multiple lung nodules and an edematous gall bladder. Three sets of Bactec blood culture (Beckton-Dickenson, Sparks, MD, USA) collected at admission grew a single morphotype of yeast in aerobic vials only. Detection times were 25.7 hours for catheter-drawn blood and 28.6 and 31.1 hours in two peripheral blood sets. Microscopic evaluation of this yeast showed blastoconidia and branching pseudohyphae similar to those in Candida parapsilosis (Fig. 1).
Fig. 1

Culture and microscopic characteristics of Lodderomyces elongisporus isolated from the patient. CHROMagar medium showing green colonies for Candida albicans (A), turquoise-blue colonies for L. elongisporus (B), and blue colonies for Candida tropicalis (C). Microscopy of the colonies on Sabouraud dextrose agar revealed ellipsoidal to elongated blastoconidia of L. elongisporus (Gram stain, ×1,000) (D). Slide cultures on corn meal agar showed abundant branched pseudohyphae (Lactophenol cotton blue stain, ×400) (E).

CHROMagar Candida medium (Komed, Sungnam, Korea) revealed a turquoise-blue colony, which differed from the green colonies of Candida albicans and blue colonies of Candida tropicalis (Fig. 1). The Vitek 2 YST ID (bioMérieux, Durham, NC) and API 20C AUX (bioMérieux) system identified it as C. parapsilosis. However, Bruker Biotyper MALDI-TOF (Brucker Daltonics, Breman, Germany) analysis indicated a likely identification of L. elongisporus (score value=1.79), followed by C. parapsilosis (score value=1.12). Sequence analysis of an internal transcribed spacer (ITS) region of ribosomal DNA demonstrated 100% homology with L. elongisporus and 97% homology with C. parapsilosis. By antifungal susceptibility testing using ATB Fungus 3 (bioMérieux), the isolate was determined to be susceptible to fluconazole, amphotericin B, voriconazole, micafungin, and caspofungin based on the CLSI breakpoint criteria for C. parapsilosis (Table 1) [2].
Table 1

Antifungal susceptibility of Lodderomyces elongisporus isolated from the patient

Antifungal agentsMinimum inhibitory concentrations (µg/mL)Interpretation (breakpoints*)
Fluconazole1.00S ( ≤ 2.00)
Amphotericin B0.25S (2.00)
Flucytosine1.00NA
Voriconazole0.12S ( ≤ 0.12)
Micafungin0.06S ( ≤ 2.00)
Caspofungin0.25S ( ≤ 2.00)

*Clinical and Laboratory Standards Institute breakpoints for Candida parapsilosis [2].

Abbreviations: NA, not applicable; S, susceptible; R, resistant.

In the present case, L. elongisporus was identified as C. parapsilosis based on biochemical methods. Such misidentification is common because of the physiological similarities and phylogenetic relatedness between the species [1345]. As previously reported, ten isolates growing turquoise-blue colonies on CHROMagar were identified as C. parapsilosis biochemically, but as L. elongisporus by ITS sequencing [1]. Therefore, the distinct color on CHROMagar provides a clue [4]. MALDI-TOF is a reliable method to identify the C. parapsilosis complex, including L. elongisporus, to the species level. This is the first report on human infection of L. elongisporus in Korea that was presented as catheter-related fungemia. It was considered a catheter-related bloodstream infection, because the patient had an indwelling central line catheter for one month and no other primary focus. L. elongisporus fungemia is rare and was only recently reported [45]. Only 15 cases have been reported to date, and two of the 15 cases were catheter-related [1345]. Indwelling catheter and the immunosuppressed status of this patient are attributed as risk factors of fungemia [5]. Large multigenic sequence analysis demonstrated that C. parapsilosis and L. elongisporus belong to the same clade, and rRNA gene sequencing confirmed their close relationship [5678]. C. parapsilosis is a well-known cause of catheter-associated fungemia via biofilm formation [6]. Therefore, L. elongisporus would be considered a potential causative agent of catheter-related fungemia. The patient was septic and died three days after admission, before removal of the indwelling catheter or antifungal treatment. To date, three cases of L. elongisporus fungemia have been reported to be fatal due to underlying comorbidity [1345]. Other cases of L. elongisporus fungemia were generally susceptible to antifungal agents and often responded well to catheter removal and treatment with azoles or echinocandin [1345]. Invasive fungemia is associated with high mortality rates (>60%) when complicated with septic shock [9]. Prompt, empirical antifungal therapy could be recommended when a patient is septic despite antimicrobials and has a high rik of candidemia like this patient. In conclusion, L. elongisporus infection may have been underestimated because of the possibility of misidentification. This case indicated that L. elongisporus fungemia could be fatal in septic condition.
  8 in total

1.  Lodderomyces elongisporus endocarditis in an intravenous drug user: a new entity in fungal endocarditis.

Authors:  K L Daveson; M L Woods
Journal:  J Med Microbiol       Date:  2012-06-08       Impact factor: 2.472

2.  Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections.

Authors:  Sun Tee Tay; Shiang Ling Na; Jennifer Chong
Journal:  J Med Microbiol       Date:  2009-02       Impact factor: 2.472

3.  Lodderomyces elongisporus masquerading as Candida parapsilosis as a cause of bloodstream infections.

Authors:  Shawn R Lockhart; Shawn A Messer; Michael A Pfaller; Daniel J Diekema
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

4.  Identification and typing of the Candida parapsilosis complex: MALDI-TOF MS vs. AFLP.

Authors:  Elena De Carolis; Lambert A M Hensgens; Antonietta Vella; Brunella Posteraro; Maurizio Sanguinetti; Sonia Senesi; Arianna Tavanti
Journal:  Med Mycol       Date:  2014-01-06       Impact factor: 4.076

5.  Catheter-Related Bloodstream Infection Due to Lodderomyces elongisporus.

Authors:  Shiro Hatanaka; Itaru Nakamura; Shinji Fukushima; Kiyofumi Ohkusu; Tetsuya Matsumoto
Journal:  Jpn J Infect Dis       Date:  2016-01-08       Impact factor: 1.362

6.  The genetic relationship of Lodderomyces elongisporus to other ascomycete yeast species as revealed by small-subunit rRNA gene sequences.

Authors:  S A James; M D Collins; I N Roberts
Journal:  Lett Appl Microbiol       Date:  1994-11       Impact factor: 2.858

7.  Isolation of Lodderomyces elongisporus from the Catheter Tip of a Fungemia Patient in the Middle East.

Authors:  Suhail Ahmad; Zia U Khan; Molly Johny; Najat M Ashour; Wehad H Al-Tourah; Leena Joseph; Rachel Chandy
Journal:  Case Rep Med       Date:  2013-04-03

Review 8.  Invasive candidiasis as a cause of sepsis in the critically ill patient.

Authors:  Julie Delaloye; Thierry Calandra
Journal:  Virulence       Date:  2013-08-27       Impact factor: 5.882

  8 in total
  3 in total

1.  Concurrent bloodstream infection with Lodderomyces elongisporus and Candida parapsilosis.

Authors:  Bryant Koh; Catriona Halliday; Raymond Chan
Journal:  Med Mycol Case Rep       Date:  2020-04-01

2.  Fatal Lodderomyces elongisporus Fungemia in a Premature, Extremely Low-Birth-Weight Neonate.

Authors:  Mohammad Asadzadeh; Noura Al-Sweih; Suhail Ahmad; Seema Khan; Wadha Alfouzan; Leena Joseph
Journal:  J Fungi (Basel)       Date:  2022-08-26

3.  Lodderomyces elongisporus: a bloodstream pathogen of greater clinical significance.

Authors:  K Al-Obaid; S Ahmad; L Joseph; Z Khan
Journal:  New Microbes New Infect       Date:  2018-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.